Christoph Grothe

725 total citations
18 papers, 573 citations indexed

About

Christoph Grothe is a scholar working on Neurology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Christoph Grothe has authored 18 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 4 papers in Genetics and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Christoph Grothe's work include Multiple Sclerosis Research Studies (4 papers), Amyotrophic Lateral Sclerosis Research (4 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). Christoph Grothe is often cited by papers focused on Multiple Sclerosis Research Studies (4 papers), Amyotrophic Lateral Sclerosis Research (4 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). Christoph Grothe collaborates with scholars based in Germany, Switzerland and France. Christoph Grothe's co-authors include Thomas Klockgether, Christoph Pohl, Susanna Moskau, Stephan Schmidt, Astrid Golla, Hans H. Schild, Frank Träber, Wolfgang Block, Karl Schaller and Rolf Schr�der and has published in prestigious journals such as SHILAP Revista de lepidopterología, Stroke and Journal of the Neurological Sciences.

In The Last Decade

Christoph Grothe

17 papers receiving 567 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christoph Grothe Germany 11 333 143 100 92 81 18 573
Tatsuo Akimura Japan 17 329 1.0× 96 0.7× 83 0.8× 98 1.1× 13 0.2× 52 723
Aristotelis Filippidis United States 16 339 1.0× 183 1.3× 38 0.4× 140 1.5× 16 0.2× 41 715
Yimo Lin United States 16 145 0.4× 58 0.4× 230 2.3× 99 1.1× 23 0.3× 37 641
Luisa Roveri Italy 12 235 0.7× 101 0.7× 18 0.2× 137 1.5× 24 0.3× 25 697
Jihye Song South Korea 15 326 1.0× 76 0.5× 23 0.2× 40 0.4× 27 0.3× 36 605
J. G. McLeod Australia 15 376 1.1× 279 2.0× 50 0.5× 112 1.2× 23 0.3× 26 741
Azize Boström Germany 17 463 1.4× 54 0.4× 161 1.6× 22 0.2× 13 0.2× 31 758
Sarah Kavanagh United States 11 111 0.3× 31 0.2× 192 1.9× 168 1.8× 50 0.6× 28 614
Jae Kyu Roh South Korea 9 106 0.3× 52 0.4× 46 0.5× 72 0.8× 16 0.2× 24 406
Michelle Mellion United States 11 260 0.8× 67 0.5× 31 0.3× 88 1.0× 44 0.5× 35 494

Countries citing papers authored by Christoph Grothe

Since Specialization
Citations

This map shows the geographic impact of Christoph Grothe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Grothe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Grothe more than expected).

Fields of papers citing papers by Christoph Grothe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christoph Grothe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Grothe. The network helps show where Christoph Grothe may publish in the future.

Co-authorship network of co-authors of Christoph Grothe

This figure shows the co-authorship network connecting the top 25 collaborators of Christoph Grothe. A scholar is included among the top collaborators of Christoph Grothe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoph Grothe. Christoph Grothe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kowarik, Markus C., Michael Ernst, Lukas Cepek, et al.. (2024). Real-world therapy management of patients with multiple sclerosis receiving cladribine tablets beyond year 4 – Results from a German cladribine cohort. Multiple Sclerosis and Related Disorders. 88. 105704–105704. 5 indexed citations
2.
Schwab, Matthias, Andrew Chan, Boris Kallmann, et al.. (2024). REBISTART: Adherence of Patients with Multiple Sclerosis to Treatment with Subcutaneous Interferon Beta in the Context of a Patient Support Program. Neurology and Therapy. 13(3). 641–653.
3.
Ziemssen, Tjalf, Anita Posevitz‐Fejfár, Lukas Cepek, et al.. (2024). Evaluation of therapy satisfaction with cladribine tablets in patients with RMS: Final results of the non-interventional study CLEVER. Multiple Sclerosis and Related Disorders. 90. 105812–105812. 2 indexed citations
4.
Stangel, Martin, V. Becker, Birte Elias-Hamp, et al.. (2021). Oral pulsed therapy of relapsing multiple sclerosis with cladribine tablets – expert opinion on issues in clinical practice. Multiple Sclerosis and Related Disorders. 54. 103075–103075. 3 indexed citations
5.
Grothe, Christoph, Falk Steffen, & Stefan Bittner. (2021). Humoral immune response and lymphocyte levels after complete vaccination against COVID-19 in a cohort of multiple sclerosis patients treated with cladribine tablets. SHILAP Revista de lepidopterología. 13. 2669587350–2669587350. 20 indexed citations
6.
Doi, André Mário, et al.. (2017). Detection of colonization by carbapenem-resistant organisms by real-time polymerase chain reaction from rectal swabs in patients with chronic renal disease. Journal of Hospital Infection. 96(2). 123–128. 8 indexed citations
7.
Chen, Bixia, Christoph Grothe, & Karl Schaller. (2013). Validation of a new neurological score (FOUR Score) in the assessment of neurosurgical patients with severely impaired consciousness. Acta Neurochirurgica. 155(11). 2133–2139. 35 indexed citations
8.
Winter, Yaroslav, Karsten Schepelmann, Annika Spottke, et al.. (2010). Health-related quality of life in ALS, myasthenia gravis and facioscapulohumeral muscular dystrophy. Journal of Neurology. 257(9). 1473–1481. 71 indexed citations
9.
Schepelmann, Karsten, Yaroslav Winter, Annika Spottke, et al.. (2009). Socioeconomic burden of amyotrophic lateral sclerosis, myasthenia gravis and facioscapulohumeral muscular dystrophy. Journal of Neurology. 257(1). 15–23. 73 indexed citations
10.
Minnerop, Martina, Karsten Specht, J. Ruhlmann, et al.. (2009). In vivo voxel-based relaxometry in amyotrophic lateral sclerosis. Journal of Neurology. 256(1). 28–34. 17 indexed citations
11.
Grothe, Christoph, et al.. (2007). Zerebelläres Syndrom bei Langerhans-Zell-Histiozytose. Der Nervenarzt. 78(4). 437–440. 3 indexed citations
12.
Linnebank, Michael, Susanna Moskau, Susan Farmand, et al.. (2006). Homocysteine and Carotid Intima-Media Thickness in a German Population. Stroke. 37(11). 2840–2842. 42 indexed citations
13.
Fischer, Dirk, Christoph Grothe, Stephan Schmidt, & Rolf Schr�der. (2004). On the early diagnosis of IVIg-responsive chronic multifocal acquired motor axonopathy. Journal of Neurology. 251(10). 1204–1207. 14 indexed citations
14.
Moskau, Susanna, et al.. (2004). Heritability of Carotid Artery Atherosclerotic Lesions. Stroke. 36(1). 5–8. 90 indexed citations
15.
Kornblum, Cornelia, et al.. (2004). Cranial magnetic resonance imaging in genetically proven myotonic dystrophy type 1 and 2. Journal of Neurology. 251(6). 710–4. 61 indexed citations
16.
Grothe, Christoph, et al.. (2001). Zerebelläres Syndrom, Exophthalmus und sekundärer Hypogonadismus bei Erdheim-Chester-Erkrankung. Der Nervenarzt. 72(6). 449–452. 7 indexed citations
17.
Pohl, Christoph, Wolfgang Block, Jochen Karitzky, et al.. (2001). Proton Magnetic Resonance Spectroscopy of the Motor Cortex in 70 Patients With Amyotrophic Lateral Sclerosis. Archives of Neurology. 58(5). 729–729. 84 indexed citations
18.
Pohl, Christoph, Wolfgang Block, Frank Träber, et al.. (2001). Proton magnetic resonance spectroscopy and transcranial magnetic stimulation for the detection of upper motor neuron degeneration in ALS patients. Journal of the Neurological Sciences. 190(1-2). 21–27. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tatsuo Akimura Breakdown of academic impact, for papers by Aristotelis Filippidis Breakdown of academic impact, for papers by Yimo Lin Breakdown of academic impact, for papers by Luisa Roveri Breakdown of academic impact, for papers by Jihye Song Breakdown of academic impact, for papers by J. G. McLeod Breakdown of academic impact, for papers by Azize Boström Breakdown of academic impact, for papers by Sarah Kavanagh Breakdown of academic impact, for papers by Jae Kyu Roh Breakdown of academic impact, for papers by Michelle Mellion
Rankless by CCL
2026